All Partner Organizations
The following Universities and organizations partner with the Office of Cancer Clinical Proteomics Research and the Clinical Proteomic Tumor Analysis Consortium with the ultimate goal of improving our ability to diagnose, treat, and prevent cancer.
- Accadia International, Inc
- Allele Biotechnology & Pharmaceuticals
- American Association for Clinical Chemistry
- Arizona State University
- Boise State University
- The Broad Institute
- Developmental Studies Hybridoma Bank at the University of Iowa
- Epitome Biosystems, Inc.
- Epitome, Inc.
- Epitomics Inc.
- European Bioinformatics Institute
- Fred Hutchinson Cancer Research Center
- Food and Drug Administration
- Harvard Affiliated Hospitals
- Human Protein Atlas (KTH Royal Institute of Technology; Stockholm, Sweden)
- Integral Molecular, Inc.
- Intrinsic Bioprobes, Inc.
- Johns Hopkins University
- Korea Institute of Science and Technology
- KTH Royal Institute of Technology
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Memorial Sloan-Kettering Cancer Center
- Meso Scale Diagnostics, LLC
- Millipore
- Monarch Life Sciences
- National Cancer Institute
- National Institute of Standards and Technology
- Oregon Health Sciences University
- Pacific Northwest National Laboratory
- The Plasma Proteome Institute
- Quadraspec, Inc.
- Rana Biosciences
- Rules-Based Medicine, Inc. (RBM)
- Sequenom, Inc.
- Stanford University
- Vanderbilt University
- Virginia Tech
- Washington University
- University of Chicago
- University of North Carolina
- The University of Texas, M.D. Anderson Cancer Center